机译:HER2阳性转移性乳腺癌患者的护理和临床结果模式?具有新诊断的阶段IV或经常性疾病,经历了一线曲妥珠单抗治疗:多中心回顾队列研究
Breast Cancer Translational Research Laboratory Institut Jules Bordet and l'Université Libre de;
Department of Medical Oncology Hospital de Santa Maria and Instituto de Medicina Molecular;
Department of Medical Oncology Clinica di Oncologia Medica IRCCS AOU San Martino-IST;
Department of Medical Oncology U.O. Oncologia Medica 2 IRCCS AOU San Martino-IST;
Department of Medical and Biological Sciences University of Udine;
Medical Oncology Istituti Clinici Scientifici Maugeri IRCCS;
Investigative Clinical Oncology (INCO) Fondazione del Piemonte per L'Oncologia Candiolo Cancer;
Department of Medical and Biological Sciences University of Udine;
Medical Oncology Istituti Clinici Scientifici Maugeri IRCCS;
Sandro Pitigliani Medical Oncology Department Hospital of Prato Azienda USL Toscana Centro;
Department of Medical Oncology U.O. Sviluppo Terapie Innovative IRCCS AOU San Martino-IST;
Oncology Unit Sant'Andrea Hospital Sapienza University of Rome and Oncology Unit ASL Roma 1;
Department of Medical Oncology Santa Maria delle Croci Hospital;
Medical Oncology IRCCS San Matteo University Hospital Foundation;
UO Oncologia 2 Universitaria Azienda Ospedaliero-Universitaria Pisana Istituto Toscano Tumori;
Department of Medical Oncology U.O. Sviluppo Terapie Innovative IRCCS AOU San Martino-IST;
Breast carcinoma; De novo disease; HER2-positivity; Metastatic disease; Surgery;
机译:HER2阳性转移性乳腺癌患者的护理和临床结果模式?具有新诊断的阶段IV或经常性疾病,经历了一线曲妥珠单抗治疗:多中心回顾队列研究
机译:(Neo)辅助曲妥珠单抗复发后HER2阳性转移性乳腺癌患者复发的基于曲妥珠单抗的一线治疗的治疗模式和临床结果:一项意大利多中心回顾性队列研究
机译:从头开始以曲妥珠单抗为基础的HER2阳性转移癌或复发性疾病的HER2阳性转移性乳腺癌患者的治疗:多中心回顾性队列研究
机译:HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关:回顾性和多中心研究
机译:Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
机译:(Neo)辅助曲妥珠单抗复发后HER2阳性转移性乳腺癌患者复发的基于曲妥珠单抗的一线治疗的治疗方式和临床结果:一项意大利多中心回顾性队列研究
机译:(Neo)辅助曲妥珠单抗复发后复发的HER2阳性转移性乳腺癌患者基于曲妥珠单抗的一线治疗的治疗模式和临床结果:一项意大利多中心回顾性队列研究